Deborah Armstrong is Professor of Oncology at Johns Hopkins. ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 17 Nov 2026
Deborah Armstrong, M.D., is Professor of Oncology at Johns Hopkins. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 5 companies, 4 NIH-funded awards (1999–2026).
- Top research focus: Ovarian / Gynecologic Cancer
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Co-author
Society of Gynecologic Oncology practice statement on frontline PARPi maintenance therapy in ovarian cancer
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Sponsor: Gynecologic Oncology Group
- Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
Sponsor: National Cancer Institute (NCI)
Industry payments
Updated 13 Nov 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Daiichi Sankyo Inc.Program year20251 payment
- AstraZeneca UK LimitedProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
68%Aromatase Inhibitor68%Anastrozole100%Part D<11 patientsNervous system
32%Benzodiazepine32%Lorazepam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Nov 2026
4 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
- Johns Hopkins University NCTN Lead Academic Site Program
Johns Hopkins University
FY2025$522,793UG1CA233196 - Johns Hopkins University NCTN Lead Academic Site Program
Johns Hopkins University
FY2024$568,290UG1CA233196
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Doximity
doximity.com/cv/deborah-armstrong-md-f8089f46
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Facebook
facebook.com/hopkinskimmel/posts/ovariancancer-is-notoriously-difficult-to-detect-says-dr-deborah-armstrong-a-med/1487566533406259
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
ascopost.com/issues/september-25-2021-supplement-gynecologic-cancers-almanac/epov-deborah-armstrong
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Other
care.healthline.com/find-care/provider/dr-deborah-armstrong-1437113255
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →care.healthline.com ↗ - Other
ocrahope.org/about/team/scientific-advisory-committee/deborah-armstrong
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ocrahope.org ↗ - Other
profiles.hopkinsmedicine.org/provider/deborah-k-armstrong/2706154
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Other
hopkinsmedicine.org/news/newsroom/news-releases/2020/09/johns-hopkins-hosts-webinar-series-about-gynecologic-cancers-and-survivorship
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org ↗ - Other
sgo.org/news/practice-statement-on-frontline-parpi-maintenance-therapy-in-ovca-published
- Other
usnews.com/topics/author/deborah-k-armstrong-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →usnews.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
Editorial & leadership roles
journal and society appointments- Serves on the Medical Oncology
Developmental Therapeutics and Phase I GOG committees, Gynecologic Oncology Group
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
- Representative of Johns Hopkins to the National Cooperative Cancer Network
ovarian and breast cancer risk reduction panels
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Member
Cancer Working Group for the Office of Research on Women's Health, National Institutes of Health
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗ - Member
Scientific Advisory Committee, Ovarian Cancer Research Alliance
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ocrahope.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ocrahope.org ↗
- Editorial review board and peer review panels
Gynecologic Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ocrahope.org ↗ - Editorial review board and peer review panels
Journal of the National Cancer Institute
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ocrahope.org ↗ - Co-principal investigator
NCI National Clinical Trials Network Lead Academic Participating Site (LAPS) at Johns Hopkins
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Breast and Ovarian Surveillance Service
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.hopkinsmedicine.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hopkinsmedicine.org ↗
- Expert Point of View
ASCO Post Gynecologic Cancers almanac supplement
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Invited discussant on maintenance olaparib study
ASCO Post coverage
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Anil Sood, MD
The University of Texas MD Anderson Cancer Center
Beth Karlan, MD
University of California, Los Angeles
Robert Bast, MD
The University of Texas MD Anderson Cancer Center
Baha Sibai, MD
McGovern Medical School at UTHealth Houston